Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
Dopamine-replacement utilizing L-DOPA is still the mainstay treatment for Parkinson’s disease (PD), but often leads to development of L-DOPA-induced dyskinesia (LID), which can be as debilitating as the motor ...
13:149
BMC Research Notes 2020
No hay comentarios:
Publicar un comentario